Top Markets
#1 Siren Siren +33.50%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.74%
#3 Wiki Cat Wiki Cat +18.74%
#4 Ribbita by Virtuals Ribbita by Virtuals +18.09%
#5 Nockchain Nockchain +17.59%
#6 TRIA TRIA +17.53%
#7 PulseChain PulseChain +16.92%
#8 Velvet Velvet +16.71%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.81%
#10 Bitway Bitway +15.71%
Coin of the day
Siren Siren
Instellingen
Taal
DUTCH
Valuta
USD
Thema
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Rang in aandelen #30950
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Aandeelprijs
$0.33274288
Marktkapitalisatie
$14.92M
Verandering (1 dag)
2.00%
Verandering (1 jaar)
-57.59%
Land
JP
Handel FunPep Company Limited (4881)

Categorie

Healthcare
P/S-ratio voor FunPep Company Limited (4881)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van FunPep Company Limited is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor FunPep Company Limited van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE